# A Multiple Myeloma Trial in Patients With Bone Metastases

> **NCT00104104** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 179 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00104104
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2011-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104104, "A Multiple Myeloma Trial in Patients With Bone Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00104104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*